Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | GBA1 | P04062 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | MANBA | O00462 | 2/20 | 0.47 |
| ▸ | IDUA | P35475 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GUSB | P08236 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.38 |
| ▸ | OGA | O60502 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | PYGB | P11216 | 2/20 | 0.37 |
| ▸ | PYGL | P06737 | 1/20 | 0.37 |
| ▸ | PYGM | P11217 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Gluconolactone SCHEMBL18465607 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL333412 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL2466472 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL7148519 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL17068350 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631270 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL24637666 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631261 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL15631260 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA | |
| Gluconolactone SCHEMBL2464302 | 1.00 | LMNA (1.00) | LMNAGBA1HIF1AMANBAIDUA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11656159-B2 | Composition for preparing biological material having excellent light transmissivity and use of composition | RIKEN (JP) | 2023-05-23 | — | — | US | disclosed |
| US-20160305889-A1 | METHOD FOR MEASURING CONCENTRATION OF TEST SUBSTANCE, AND DETECTION APPARATUS | OSAKA UNIVERSITY (JP) | 2016-10-20 | — | — | US | disclosed |
| US-20160305889-A1 | METHOD FOR MEASURING CONCENTRATION OF TEST SUBSTANCE, AND DETECTION APPARATUS | OSAKA UNIVERSITY (JP) | 2016-10-20 | — | — | US | disclosed |
| US-20160168183-A1 | Conjugates Containing Hydrophilic Spacer Linkers | ENDOCYTE INC (US) | 2016-06-16 | — | — | US | disclosed |
| US-9359322-B2 | C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growth | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9359322-B2 | C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and methods of using the same to inhibit neoplastic cell growth | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-06-07 | — | — | US | disclosed |
| US-9138484-B2 | Conjugates containing hydrophilic spacer linkers | ENDOCYTE, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20140271474-A1 | INHIBITOR PROBES FOR IMAGING SODIUM-GLUCOSE COTRANSPORTERS IN HEALTH AND DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-09-18 | — | — | US | disclosed |
| US-20140073761-A1 | CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS | ENDOCYTE, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| US-20140073761-A1 | CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS | ENDOCYTE, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| US-20100323973-A1 | CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS | ENDOCTYE, INC. | 2010-12-23 | — | — | US | disclosed |
| US-20090215706-A1 | C-LINKED GLUCURONIDE OF N-(4-HYDROXYBENZYL) RETINONE, ANALOGS THEREOF, AND METHOD OF USING THE SAME TO INHIBIT NEOPLASTIC CELL GROWTH | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION | 2009-08-27 | — | — | US | disclosed |
| US-20090133162-A1 | Method of increasing plant organ and seed size in a plant | FERNANDES MARY | 2009-05-21 | — | — | US | disclosed |
| US-7528114-B2 | C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-05-05 | — | — | US | disclosed |
| US-7335812-B2 | Method of increasing plant organ and seed size in a plant | MONSANTO TECHNOLOGY LLC (US) | 2008-02-26 | — | — | US | disclosed |
| US-20070224490-A1 | Suspension for the Generation of a Current of Electrons and the Use and the Preparation Thereof | JANSSEN CATHARINA P | 2007-09-27 | — | — | US | disclosed |
| US-20070108057-A1 | Enzyme immobilization for electroosmotic flow | NATIONAL SCIENCE FOUNDATION | 2007-05-17 | — | — | US | disclosed |
| US-7172682-B2 | Enzyme immobilization for electroosmotic flow | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-02-06 | — | — | US | disclosed |
| US-7172682-B2 | Enzyme immobilization for electroosmotic flow | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-02-06 | — | — | US | disclosed |
| US-20070000781-A1 | ENZYME IMMOBILIZATION FOR ELECTROOSMOTIC FLOW | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070000781-A1 | ENZYME IMMOBILIZATION FOR ELECTROOSMOTIC FLOW | MGAM, PNKP, AGL | LMNA 2979/4885GBA1 1644/4885HIF1A 4115/4885 |
| US-20140271474-A1 | INHIBITOR PROBES FOR IMAGING SODIUM-GLUCOSE COTRANSPORTERS IN HEALTH AND DISEASE | SLC5A1, SLC5A2, SLC2A4 | LMNA 4229/4885GBA1 220/4885HIF1A 992/4885 |
| US-20160168183-A1 | Conjugates Containing Hydrophilic Spacer Linkers | CD44, HAVCR2, HCAR1 | LMNA 903/4885GBA1 309/4885HIF1A 411/4885 |
| US-20090215706-A1 | C-LINKED GLUCURONIDE OF N-(4-HYDROXYBENZYL) RETINONE, ANALOGS THEREOF, AND METHOD OF USING THE SAME TO INHIBIT NEOPLASTIC CELL GROWTH | UGT2B17, ALDH1A2, UGT2B7 | LMNA 1714/4885GBA1 906/4885HIF1A 1802/4885 |
| US-20100323973-A1 | CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS | CD44, HAVCR2, HCAR1 | LMNA 903/4885GBA1 309/4885HIF1A 411/4885 |
| US-20140073761-A1 | CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS | CD44, HAVCR2, HCAR1 | LMNA 903/4885GBA1 309/4885HIF1A 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.